Governor JB Pritzker and the Illinois Department of Public Health (IDPH) announced that a new, long-acting HIV treatment called Cabenuva will become available to thousands of people in Illinois starting in January 2023. The injectable medication, which is being added to the list of treatments that are available through the State’s AIDS Drug Assistance Program (ADAP), is administered once a month or every other month and replaces oral medications that need to be taken daily. IDPH officials note that use of Cabenuva is expected to increase medication compliance which will not only improve health outcomes but also potentially reduce transmission of the HIV virus to others. Funding for the initiative comes from the federal Ryan White CARE Act program, state general revenue funds and drug rebate dollars. IDPH data indicates more than 36,000 people in Illinois are diagnosed with HIV. The state drug assistance program provides medication and other services for more than 15,000 of those individuals. For more information about the Illinois AIDS Drug Assistance Program, go to: https://dph.illinois.gov/topics-services/diseases-and-conditions/hiv-aids.html